AIFF — Stock Film
STOCK FILMSCENE 1/11AIFF · $1.08
Stock Expert AI presents
AIFF
Firefly Neuroscience, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Firefly Neuroscience, Inc. A quick introduction.

On the stock market since 2002, it operates in the world of technology. It has 13 employees. Now — the numbers.

on the stock market since 2002
13 employees
$39.1M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $18.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

In the vault right now:
$0
DEBT: $0
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

What executives did with their own stock over the last 12 months:
14 buy10 sell

Executives buying with their own money is usually read as confidence in the company’s future.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
3
very weak

Clearly below the class average.

FINANCIAL STRENGTH
48
weak

Clearly below the class average.

VALUATION
7
very weak

Clearly below the class average.

GROWTH
21
very weak

Clearly below the class average.

PRICE MOMENTUM
25
very weak

Clearly below the class average.

WORTH WATCHING

Business Quality: Profit power and business quality trail similar companies in the sector.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 99% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $1.1M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Executives are buying their own stock

Over the last 12 months, company executives reported 14 buys and 10 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $19.9M against $1.1M in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, AIFF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: AIFF is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film